Who has invested in ImmunoVec?

No investors are named on the public record for ImmunoVec yet.

ImmunoVec Funding: $4.3M Raised, Series A (2021)

ImmunoVec funding overview

ImmunoVec is based in Los Angeles, California. ImmunoVec has raised $4.3M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in November 2021. The round record for ImmunoVec runs through 2021; nothing later has been disclosed.

ImmunoVec at a glance

Total raised: $4.3M
Latest round: Series A
Latest round date: November 2021
Headquarters: Los Angeles, California

Frequently asked about ImmunoVec funding

How much has ImmunoVec raised?: ImmunoVec has raised $4.3M in total disclosed funding across the rounds on record.
Who has invested in ImmunoVec?: No investors are named on the public record for ImmunoVec yet.
What was the latest ImmunoVec funding round?: The most recent disclosed round is a Series A, announced in November 2021.
Where is ImmunoVec based?: ImmunoVec is based in Los Angeles, California.
When did ImmunoVec last raise?: The last disclosed ImmunoVec round closed in November 2021 at Series A.

ImmunoVec totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Los Angeles below to benchmark round size and investor mix.

ImmunoVec Funding: $4.3M Raised, Series A (2021)

ImmunoVec funding overview

ImmunoVec at a glance

Frequently asked about ImmunoVec funding

Companies related to ImmunoVec (18)

Browse related funding lists (5)